Literature DB >> 12643123

Dermatologic conditions associated with diabetes.

Karen Nern1.   

Abstract

The development of skin manifestations of diabetes affects up to two thirds of patients with both types 1 and 2 diabetes mellitus. Cutaneous manifestations of diabetes occur because of the microvascular complications of diabetes, impaired wound healing, and other yet undetermined mechanisms. This article summarizes the most frequent skin findings in patients with diabetes, and proposes treatment of some complications.

Entities:  

Mesh:

Year:  2002        PMID: 12643123     DOI: 10.1007/s11892-002-0058-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  27 in total

Review 1.  An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.

Authors:  A K Gupta; J Q Del Rosso
Journal:  Int J Dermatol       Date:  2000-06       Impact factor: 2.736

2.  Quantitative determination of skin thickness in diabetes mellitus: relationship to disease parameters.

Authors:  A C Huntley; R M Walter
Journal:  J Med       Date:  1990

Review 3.  Necrobiosis lipoidica.

Authors:  M H Lowitt; J S Dover
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

4.  Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.

Authors:  A K Gupta; N Konnikov; P MacDonald; P Rich; N W Rodger; M W Edmonds; R McManus; R C Summerbell
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

5.  A clinical observation of scleredema adultorum and its relationship to diabetes.

Authors:  Y W Rho; K B Suhr; J H Lee; J K Park
Journal:  J Dermatol       Date:  1998-02       Impact factor: 4.005

6.  Dermopathy in the diabetic syndrome.

Authors:  G W Binkley
Journal:  Arch Dermatol       Date:  1965-12

7.  Glucose effects on skin keratinocytes: implications for diabetes skin complications.

Authors:  N Spravchikov; G Sizyakov; M Gartsbein; D Accili; T Tennenbaum; E Wertheimer
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

8.  [Successful symptomatic tazarotene treatment of juvenile acanthosis nigricans of the familial obesity-associated type in insulin resistance].

Authors:  E Weisshaar; B Bonnekoh; I Franke; H Gollnick
Journal:  Hautarzt       Date:  2001-06       Impact factor: 0.751

9.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

Review 10.  The scleroderma-like syndrome of insulin-dependent diabetes mellitus.

Authors:  R Brik; M Berant; P Vardi
Journal:  Diabetes Metab Rev       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.